DURACILLIN A.S. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duracillin A.s., and when can generic versions of Duracillin A.s. launch?
Duracillin A.s. is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in DURACILLIN A.S. is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duracillin A.s.
A generic version of DURACILLIN A.S. was approved as penicillin g procaine by KING PHARMS LLC on December 31st, 1969.
Summary for DURACILLIN A.S.
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Patent Applications: | 4,026 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DURACILLIN A.S. at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DURACILLIN A.S.
US Patents and Regulatory Information for DURACILLIN A.S.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | DURACILLIN A.S. | penicillin g procaine | INJECTABLE;INJECTION | 060093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |